James Bearden to Antibodies, Neoplasm
This is a "connection" page, showing publications James Bearden has written about Antibodies, Neoplasm.
Connection Strength
0.020
-
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network. Cancer. 2008 Mar 15; 112(6):1288-95.
Score: 0.020